dsdsa

product

High Purity Pharmaceutical Grade 857890-39-2 Lenvatinib mesylate for Cancer Treatment

Short Description:


  • Purity: ≧99%, white or off-white powder
  • Quality Standard: In-House or as require
  • Certificate: COA, MOA, MSDS, etc
  • Capacity: 5Kg/Month
  • Shelf Life: 3 Years
  • Application: A type of chemotherapy called targeted therapy; anticancer
  • Team Advantage: Experienced export sales team with professional train in factory
  • Product Detail

    FAQ

    Product Tags

    Product name Lenvatinib mesylate
    Synonyms 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate
    CAS No. 857890-39-2
    Appearance Pale reddish yellow to white crystalline powder
    Molecular Formula C21H19ClN4O4.CH4O3S
    Molecular Weight 522.96
    Usage Research purpose
    Packing As per your request
    Storage Preserve in tight,light-resistant containers in a cool place

     

    Lenvatinib mesylate CAS:857890-39-2

    ITEMS

    STANDARDS

    RESULTS

    CHARACTERISTICS

    Pale reddish yellow to white crystalline powder

    Almost white crystalline powder

    IDENTIFICATION

    1、By IR2、By HPLC

    Complies

    SOLUBILITY

    Slightly soluble in water;practically insoluble in  ethanol

    Complies

    WATER

    ≤1.0%

    0.26%

    RESIDUE ON IGNITION

    ≤0.2%

    0.08%

    HEAVY METALS

    ≤20ppm

    Complies

    RELATIVE SUBSTANCE

    Any individual impurity:≤0.5 %

    0.21%

    Total Impurities:≤1.0 %

    0.43%

    ASSAY 98.0~102.0%

    99.3%

    Conclusion:It complies to enterprise standard

    Company Information

    √ Management layer’s full experience in factory and skilled technicians followers;
    √ Quality is always our top consideration, Strict QC system;
    √ 11 years experienced exporting sales team;
    √ Independent R&D lab;
    √ Two signed long term GMP workshops;
    √ Rich resources of plenty idle factories for customized project;
    √ High Efficiency working team with consistent path.
    imgsafSDGSHDASFG

  • Previous:
  • Next:

  • Write your message here and send it to us